← Back to Clinical Trials
Recruiting NCT07153627

NCT07153627 Rectal Ozone as Neuroprotector Post CNS Insult in Children

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07153627
Status Recruiting
Phase
Sponsor Al-Azhar University
Condition Rectal Ozone
Study Type INTERVENTIONAL
Enrollment 120 participants
Start Date 2025-05-01
Primary Completion 2025-10-01

Eligibility & Interventions

Sex All sexes
Min Age 1 Month
Max Age 18 Years
Study Type INTERVENTIONAL
Interventions
Rectal ozone sessionsConventional rehabilitation program

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 120 participants in total. It began in 2025-05-01 with a primary completion date of 2025-10-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to evaluate the efficacy of rectal ozone therapy as a neuroprotective modality in Pediatric acquired brain injury.

Eligibility Criteria

Inclusion Criteria: * Age from 1 month to 18 years. * Both sexes. * Children admitted to the pediatric intensive care unit (PICU) with acquired neurological insult. * Children with neurological sequelae * Children who are exposed to acquired brain injury, e.g., traumatic brain injury, cardiac arrest, intracranial hemorrhage, central nervous system infections, stroke, tumor, or hypoxia, with neurological sequelae diagnosed by neurological examination and magnetic resonance imaging (MRI), to detect that disorder early. Exclusion Criteria: * Patients with no degree of disability or sequelae. * Patients not fit for Rectal ozone therapy. * Patients with active epilepsy and recurrent seizures. * Children with a positive family history of degenerative brain insults. * Children with behavioral problems.

Contact & Investigator

Central Contact

Ahmed M Asfour, Master

✉ drahmedasfour14@gmail.com

📞 00201017440223

Frequently Asked Questions

Who can join the NCT07153627 clinical trial?

This trial is open to participants of all sexes, aged 1 Month or older, up to 18 Years, studying Rectal Ozone. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07153627 currently recruiting?

Yes, NCT07153627 is actively recruiting participants. Contact the research team at drahmedasfour14@gmail.com for enrollment information.

Where is the NCT07153627 trial being conducted?

This trial is being conducted at Cairo, Egypt.

Who is sponsoring the NCT07153627 clinical trial?

NCT07153627 is sponsored by Al-Azhar University. The trial plans to enroll 120 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology